Wu, C.-Y., Shi, Q., Tomsic, J., Meyers, J. P., Frankel, W. L., Timmers, C. D., … Goldberg, R. M. (2016). Deletions in HSP110 T₁₇ and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147. In Journal of Clinical Oncology (Vol. 34, pp. e15148–e15148). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e15148

Wu, Christina Sing-Ying, Qian Shi, Jerneja Tomsic, Jeffrey P. Meyers, Wendy L. Frankel, Cynthia Dawn Timmers, Leonard Saltz, et al. “Deletions in HSP110 T₁₇ and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147.” In Journal of Clinical Oncology, 34:e15148–e15148. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e15148.

Wu CS-Y, Shi Q, Tomsic J, Meyers JP, Frankel WL, Timmers CD, et al. Deletions in HSP110 T₁₇ and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e15148–e15148.

Wu, Christina Sing-Ying, et al. “Deletions in HSP110 T₁₇ and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e15148–e15148. Crossref, doi:10.1200/jco.2016.34.15_suppl.e15148.

Wu CS-Y, Shi Q, Tomsic J, Meyers JP, Frankel WL, Timmers CD, Saltz L, Alberts SR, Niedzwiecki D, Sargent DJ, Hampel H, De La Chapelle A, Goldberg RM. Deletions in HSP110 T₁₇ and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e15148–e15148.